PACIULLO, FRANCESCO
 Distribuzione geografica
Continente #
EU - Europa 1.791
AS - Asia 1.700
NA - Nord America 1.136
SA - Sud America 356
AF - Africa 53
OC - Oceania 14
Totale 5.050
Nazione #
US - Stati Uniti d'America 1.048
RU - Federazione Russa 1.021
SG - Singapore 599
CN - Cina 436
IT - Italia 328
BR - Brasile 294
HK - Hong Kong 216
VN - Vietnam 138
BD - Bangladesh 131
FR - Francia 95
DE - Germania 93
GB - Regno Unito 62
IN - India 57
CA - Canada 53
NL - Olanda 44
AT - Austria 32
AR - Argentina 23
IE - Irlanda 21
IQ - Iraq 18
PL - Polonia 18
MX - Messico 17
ZA - Sudafrica 16
AU - Australia 14
ES - Italia 14
ID - Indonesia 13
SE - Svezia 12
TR - Turchia 12
FI - Finlandia 10
LT - Lituania 10
PE - Perù 9
PH - Filippine 8
CO - Colombia 7
JP - Giappone 7
CH - Svizzera 6
CL - Cile 6
KE - Kenya 6
MY - Malesia 6
PK - Pakistan 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
VE - Venezuela 6
CR - Costa Rica 5
DO - Repubblica Dominicana 5
EC - Ecuador 5
IL - Israele 5
MA - Marocco 5
RO - Romania 5
AE - Emirati Arabi Uniti 4
BB - Barbados 4
BE - Belgio 4
BW - Botswana 4
GR - Grecia 4
LA - Repubblica Popolare Democratica del Laos 4
NG - Nigeria 4
PY - Paraguay 4
UA - Ucraina 4
BG - Bulgaria 3
ET - Etiopia 3
JO - Giordania 3
KZ - Kazakistan 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
AZ - Azerbaigian 2
EG - Egitto 2
LK - Sri Lanka 2
MD - Moldavia 2
NP - Nepal 2
SC - Seychelles 2
SN - Senegal 2
TZ - Tanzania 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CD - Congo 1
CG - Congo 1
CY - Cipro 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
IR - Iran 1
JM - Giamaica 1
KR - Corea 1
LB - Libano 1
LI - Liechtenstein 1
MN - Mongolia 1
MZ - Mozambico 1
PS - Palestinian Territory 1
SV - El Salvador 1
TH - Thailandia 1
TL - Timor Orientale 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
YE - Yemen 1
Totale 5.050
Città #
Singapore 355
Hong Kong 214
Moscow 185
Ashburn 174
Dallas 123
San Jose 119
Hefei 77
New York 74
Lauterbourg 70
Shanghai 62
Milan 58
Ho Chi Minh City 46
Los Angeles 43
Hanoi 34
São Paulo 32
Orem 31
Boardman 29
Rome 27
Munich 26
Nuremberg 26
Beijing 23
Santa Clara 21
Dublin 19
Montreal 17
Denver 15
Frankfurt am Main 15
Vienna 15
London 14
Warsaw 14
Amsterdam 13
Brooklyn 13
Council Bluffs 12
Manchester 12
Boston 11
Chennai 11
Chicago 11
Johannesburg 11
Atlanta 10
Bengaluru 10
Buffalo 10
Falkenstein 10
Rio de Janeiro 10
Stockholm 10
Turin 10
Guangzhou 9
Phoenix 9
Sydney 9
Da Nang 8
Mumbai 8
Belo Horizonte 7
Haiphong 7
Helsinki 7
Miami 7
Poplar 7
Tokyo 7
Baghdad 6
Bologna 6
Catania 6
Genoa 6
Lima 6
Mexico City 6
Naples 6
San Francisco 6
St Louis 6
Tashkent 6
Tianjin 6
Toronto 6
Ankara 5
Bari 5
Calgary 5
Cleveland 5
Florence 5
Houston 5
Palermo 5
Zurich 5
Bridgetown 4
Curitiba 4
Dhaka 4
Fortaleza 4
Gaborone 4
Guarulhos 4
Hangzhou 4
Hayes 4
Jundiaí 4
Las Vegas 4
Nairobi 4
Natal 4
Pescara 4
Santo André 4
Santo Domingo 4
Seattle 4
Shenzhen 4
Vientiane 4
Addis Ababa 3
Amman 3
Asunción 3
Augusta 3
Birmingham 3
Biên Hòa 3
Bogotá 3
Totale 2.412
Nome #
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI 130
Prevalence of potentially inappropriate medications and risk of adverse clinical outcome in a cohort of hospitalized elderly patients: results from the REPOSI Study 130
Appropriateness of antiplatelet therapy for primary and secondary cardio‐ and cerebrovascular prevention in acutely hospitalized older people 118
Defining Aging Phenotypes and Related Outcomes: Clues to Recognize Frailty in Hospitalized Older Patients 117
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 113
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 104
Antipsychotic prescription and mortality in hospitalized older persons 100
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 97
Baseline and post-surgery endothelial progenitor cell levels in patients with early-stage non-small-cell lung carcinoma: impact on cancer recurrence and survival 97
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 97
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 91
Antithrombotic treatment of retinal vein occlusion: a position statement from the Italian Society on Thrombosis and Haemostasis (SISET) 90
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly 89
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 88
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 87
Association of Neutrophil Activation, More Than Platelet Activation, with Thrombotic Complications in Coronavirus Disease 2019 85
Deficiency of natural anticoagulants: how should we manage cardiovascular prevention? 83
Need for deprescribing in hospital elderly patients discharged with a limited life expectancy: The REPOSI study 82
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 82
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study 79
Under-detection of delirium and impact of neurocognitive deficits on in-hospital mortality among acute geriatric and medical wards 79
Gender-differences in disease distribution and outcome in hospitalized elderly : Data from the REPOSI study 79
Antithrombotic treatment for retinal vein occlusion: a systematic review and meta-analysis 79
Prevalence, characteristics and treatment of chronic pain in elderly patients hospitalized in internal medicine wards 78
Sex-Differences in the Pattern of Comorbidities, Functional Independence, and Mortality in Elderly Inpatients: Evidence from the RePoSI Register 76
Measurement of arterial stiffness in antiphospholipid syndrome: a step forward in cardiovascular risk stratification? 76
Disability, and not diabetes, is a strong predictor of mortality in oldest old patients hospitalized with pneumonia 75
Effect of statin intake on FVIII levels and bleeding outcomes in hypercholesterolemic patients with hemophilia A 75
Risk factors for three-month mortality after discharge in a cohort of non-oncologic hospitalized elderly patients: Results from the REPOSI study 74
Antithrombotic treatment of asymptomatic carotid atherosclerosis: a medical dilemma 73
Use of non-steroidal anti-inflammatory drugs and analgesics in a cohort of hospitalized elderly patients: Results from the REPOSI study 72
Drug-drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 71
Prevalence and Risk Factors Associated with Use of QT-Prolonging Drugs in Hospitalized Older People 71
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 71
Antiplatelet Therapy in Low-Platelet-Count Patients After Percutaneous Coronary Intervention for Acute Coronary Syndromes 70
Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study 70
Heart failure and chronic kidney disease in a registry of internal medicine wards 70
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 70
The stigma of low opioid prescription in the hospitalized multimorbid elderly in Italy 70
Pattern of in‐hospital changes in drug use in the older people from 2010 to 2016 68
Effect of statins on measures of coagulation: potential role of low-density lipoprotein receptors 66
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 66
Antibiotic use and associated factors in a large sample of hospitalised older people 65
Role of Increased Lipoprotein (a) in Retinal Vein Occlusion: A Systematic Review and Meta-analysis 64
Inappropriate prescription of allopurinol and febuxostat and risk of adverse events in the elderly: results from the REPOSI registry 59
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients 59
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation 58
Therapeutic Duplicates in a Cohort of Hospitalized Elderly Patients: Results from the REPOSI Study 57
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 54
The response of the emergency-urgency system in Umbria during the COVID-19 pandemic 54
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 53
PCSK9 at the crossroad of cholesterol metabolism and immune function during infections 53
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 53
Long noncoding RNAs: new insights into non-small cell lung cancer biology, diagnosis and therapy 53
Vitamin B12 levels in patients with retinal vein occlusion and their relation with clinical outcome: a retrospective study 52
Rivaroxaban Plasma Levels and Levetiracetam RESPONSE 51
Role of endothelial dysfunction in the thrombotic complications of COVID-19 patients 50
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 49
High - but not standard-dose atorvastatin prevents the increase of plasma matrix metalloproteinase-2 triggered by acute coronary syndromes 47
Living alone as an independent predictor of prolonged length of hospital stay and non-home discharge in older patients 46
Impact of COVID-19 and COVID-19 vaccination on high-risk patients with antiphospholipid syndrome: a nationwide survey 45
Rivaroxaban Plasma Levels and Levetiracetam: A Case Report 44
Long-term treatment with thalidomide for severe recurrent hemorrhage from intestinal angiodysplasia in Glanzmann Thrombasthenia 43
On-treatment C-reactive protein and HDL cholesterol levels in patients at intermediate cardiovascular risk: Impact on carotid intima-media thickness 43
Strategies for prevention of SARS-CoV-2 infection in a rural Emergency Department 41
Increased plasma PCSK-9 is associated with restenosis in patients undergoing carotid endarterectomy 40
Olanzapine-associated hypothermia: a case report of a rare event 39
Eltrombopag in preparation for surgery in patients with severe MYH9-related thrombocytopenia 39
Epidemiology of emergency calls for time-dependent acute illnesses during COVID-19 outbreak in Umbria region (Italy) 38
Persistence on apixaban in atrial fibrillation patients: a retrospective multicentre study 38
PCSK9 in Haemostasis and Thrombosis: Possible Pleiotropic Effects of PCSK9 Inhibitors in Cardiovascular Prevention 37
Reduced survival in patients with early-stage non-small-cell lung cancer is associated with high pleural endothelial progenitor cell levels 36
Eltrombopag to allow chemotherapy in a patient withMYH9-related inherited thrombocytopenia and pancreatic cancer 36
Pleiotropic effects of PCSK9-inhibition on hemostasis: Anti-PCSK9 reduce FVIII levels by enhancing LRP1 expression 33
Inappropriate prescription of benzodiazepines in acutely hospitalized older patients 33
Lipoprotein(a) and inflammation: A dangerous duet leading to endothelial loss of integrity 31
Totale 5.151
Categoria #
all - tutte 18.792
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.792


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202428 0 0 0 0 0 0 0 0 0 0 19 9
2024/20251.028 43 2 6 80 52 110 252 70 99 107 89 118
2025/20264.095 299 346 193 433 292 229 329 307 1.041 233 255 138
Totale 5.151